ResMed/RMD

$178.00

0.22%
-
1D1W1MYTD1YMAX

About ResMed

ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.

Ticker

RMD

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Michael Farrell

Employees

10,140

Headquarters

San diego, United States

ResMed Metrics

BasicAdvanced
$25.57B
Market cap
28.80
P/E ratio
$6.04
EPS
0.71
Beta
$1.84
Dividend rate
1.1%
Dividend yield
$25.57B
0.70553
$243.52
$132.24
1.03M
$1.84
3.112
1.891
27.149
27.37
30.39%
39.964
19.64%
13.11%
21.66%
14.74%
28.798
5.677
5.705
23.418
37.985
0.81%
1.06%
1.1%
19.69%
9.73%
12.61%
12.56%
4.1%

What the Analysts think about ResMed

Analyst Ratings

Majority rating from 15 analysts.
Buy

Price Targets

Average projection from 10 analysts.
13.87% upside
High $227.00
Low $164.00
$178.00
Current price
$202.68
Average price target

ResMed Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
17.95% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$1.16B
5.49%
Net income
$208.8M
-4.83%
Profit margin
17.95%
-9.8%

ResMed Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 4.7%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$1.68
$1.60
$1.64
$1.88
-
Expected
$1.59
$1.69
$1.62
$1.80
$1.90
Surprise
5.88%
-5.37%
1.42%
4.7%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for ResMed stock?

ResMed (RMD) has a market cap of $25.57B as of April 19, 2024.

What is the P/E ratio for ResMed stock?

The price to earnings (P/E) ratio for ResMed (RMD) stock is 28.8 as of April 19, 2024.

Does ResMed stock pay dividends?

Yes, the ResMed (RMD) stock pays dividends to shareholders. As of April 19, 2024, the dividend rate is $1.84 and the yield is 1.1%. ResMed has a payout ratio of 30.39% on a trailing twelve-month basis.

When is the next ResMed dividend payment date?

The next ResMed (RMD) dividend payment date is unconfirmed.

What is the beta indicator for ResMed?

ResMed (RMD) has a beta rating of 0.71. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the ResMed stock price target?

The target price for ResMed (RMD) stock is $202.68, which is 13.87% above the current price of $178. This is an average based on projections from 10 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell ResMed stock

Buy or sell ResMed stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing